Eisai's Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint Sep 28, 2022 14:15 HKT/SGT Read More
エーザイ、レカネマブがグローバル大規模臨床第III相CLARITY AD検証試験で統計学的に高度に有意な臨床症状の悪化抑制を示し、主要評価項目を達成 Sep 28, 2022 09:00 JST Read More
Eisai: Metoject Subcutaneous Injection Syringe (Methotrexate) Approved in Japan for Rheumatoid Arthritis Sep 26, 2022 19:14 HKT/SGT Read More
Fujitsu, Tohoku University embark on strategic alliance to realize 'Well-being Society' Sep 26, 2022 11:18 HKT/SGT Read More
AIM Vaccine Announces Proposed Listing on the Main Board of SEHK Sep 23, 2022 17:06 HKT/SGT Read More
Agilis Robotics Targeting its Pre-B Round Fund-raising to be Completed by 2022 Sep 22, 2022 14:13 HKT/SGT Read More
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah Sep 21, 2022 19:00 HKT/SGT Read More